bloating after stopping semaglutide What You Should Know About Withdrawal Symptoms Semaglutide Side Effects Week by

The STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial programme demonstrated that adults using semaglutide 2.4 mg weekly alongside lifestyle intervention lost an average of approximately 15% of their body weight over 68 weeks, compared to around 2.4% with placebo. NICE approved Wegovy for use in specialist weight management services in the UK in 2023 (TA875), recognising its clinical effectiveness. Ongoing research continues to explore its cardiovascular benefits, with the SELECT trial showing a significant reduction in major cardiovascular events in people with obesity

GLP-1 (glucagon-like peptide-1) is a hormone that regulates insulin and controls appetite, making it crucial for weight management and blood sugar balance

Allulose vs

Two of the most talked-about metabolism supplements on the market both feature Akkermansia muciniphila as a key ingredient, but they take very different approaches to formulation

Louis Bariatrics helps patients manage GLP-1 medications safely.